Panel discussion: Which patient/which treatment, case stories Nicos Labropoulos,USA
15:30-16:00
Coffee break/Visit to exhibition
16.00-17.30
Clinical validation of the safety and efficacy of Anti-Xa and Anti-IIa drugs! Are they really superior to heparin? Chair: Andrew Nicolaides, Dieter Welzel
16.00
A survey of new anti-Xa and anti-IIa drugs. Jawed Fareed, USA
16.20
Comparison of heparins and new anticoagulants for venous thrombosis
Dieter Welzel, Germany
16.40
Validation of the clinical trials on new anticoagulants. Are comparisons justified? Russel Hull, Canada
17.00
Net clinical benefit of new anti-Xa and anti-IIa drugs. Are these superior to heparins and warfarin? David Van Thiel, USA
17.20
Closing Remarks. Andrew Nicolaides, Cyprus
Discussion
17.30-18.50
Free Paper Session 1 Chair: Niels Bækgaard, Andrew Nicolaides
17.30
1.1
Dutch consensus on duplex guided foam sclerotherapy in the light of other European guidelines.
Sommer A, Shadid N.
Dept of Dermatology, MUMC+, Maastricht, The Netherlands Submitted in consideration for the EVF Prize
1.2
Five year outcome of ultrasound guided foam sclerotherapy for saphenous trunks.
Coleridge Smith P.
British Vein Institute, London, UK
1.3
Seasonal variation of superficial venous thrombophlebitis.
Kakkos S, Lampropoulos G, Papadoulas S, Ntouvas I, Tsolakis I.
Dept of Vascular Surgery, University of Patras Medical School, Patras, Greece Submitted in consideration for the EVF Prize
1.4
Effects of tetradecyl sulphate on coagulation profile, platelet aggregation profile and fibrinokinetics: Implications on sclerotherapy
Kalodiki E, Adiguzel C*, Iqbal O*, Geroulakos G.
Ealing Hospital and Imperial College, London, UK.
* Dept of Pathology, Loyola University, Chicago, Ill, USA
18.50-19.30
General Assembly
19.30-21.00
Reception at the exhibition area
Saturday 6. June
09:00-10:00
Free Paper Session 2 (5 min presentations/5 min discussions) Chair: Alun Davies, Anthony Comerota
09:00
2.1
Surgery of the small saphenous vein: A personal series
Vandendriessche M. Ghent, Belgium
09:10
2.2
Calculation of energy in radiofrequency segmental thermal ablation of great saphenous vein.
Lebard C, Daniel C, Zuccarelli F.
Clinique Internationale du Parc Monceau, Paris, France
09:20
2.3
Correlation between chronic venous disease and the static foot disorders.
Uhl J-F*, Chahim M**.
* Varicose Veins Surgical Centre, Paris Defense, Neuilly-sur-Seine, France.
** Hopital Corentin, Issy les Moulineaux, France Submitted in consideration for the EVF Prize
09:30
2.4
D-dimer measurement to all suspicions of venous thromboembolism, independently of pre-test clinical probability (Wells criteria), reject with safety one of four patients and is economical for the institution, avoiding unnecessary image explorations
Casals FJ*^, Bernaudo D*~, Lozano N*#, and the UFMATE Team.
*Thromboembolism Unit (UFMATE),
^Haemotherapy-Haemostase,
#Fundacio Clinic, Hospital Clinic, Barcelona, Spain,
~Unita Medicina General, Ospedale S Paolo, Napoli, Italy Submitted in consideration for the EVF Prize
09:40
2.5
Results of endovenous laser ablation of insufficient communicant veins in the treatment of chronic venous insufficiency.
Sokolov AL, Kyadov KV, Loutsenko MM, Lavrenko SV,
Center of Treatment and Rehabilitation, Moscow, Russia
09:50
2.6
Local anaesthetic treatment of varicose veins in an outpatient setting
Metcalfe MJ, Gatenby PA, Reise JA, Franklin JJ.
Charing Cross Hospital, London, UK Submitted in consideration for the EVF Prize
10:00 – 10:30
Coffee break/Visit to Exhibition
10:30 - 12.30
Free Paper Session 3 Chair: Leif Panduro Jensen, Marianne Vandendriessche
10.30
3.1
Clinical research studies on venous thrombolysis at the National Institutes of Health, USA
Chang R, Lozier J, Kam AW, Chen EA, Shawker TH, Wesley RA, Mao EA, Wyrick DA, Horne MK.
National Institutes of Health, Bethesda, Md, USA Submitted in consideration for the EVF Prize
10.50
3.2
The efficacy of single daily dose of enoxaparin treatment in acute venous thromboembolism: Trombotek study
Kurtoglu M.
Istanbul University, Istanbul Medical Faculty, Department of General Surgery, Capa, Istanbul
11.10
3.3
Atresia of the inferior vena cava and iliofemoral venous thrombosis. Experiences with catheter-directed thrombolysis
Broholm R, Baekgaard N, Just S, Jorgensen M, Jensen, Panduro Jensen L.
Department of Vascular Surgery, Department of Radiology and the Thrombosis Centre, Gentofte University Hospital, Gentofte, Denmark Submitted in consideration for the EVF Prize
11.30
3.4
Should retrievable filters be retrieved?
Kodati S, Patel VM, Makanjuola J, Mobasheri M, Hussain T.
Department of
Vascular Surgery, Northwick Park Hospital, Harrow, UK
11.50
3.5
Techniques, treatments and outcomes of patients with delayed inferior vena-cava perforation from filter placement
McLafferty RB, Moore C, Hood D, Hodgson KJ.
Southern Illinois University, Springfield, Illinois, USA
12.10
3.6
Venous thromboembolism in patients with IVC Aplasia
Gasparis AP, Labropoulos N, Lebda P, Spentzoouris G, Leon L, Borge M, Tassiopoulos AK, Pappas PJ.
Stonybrook University Medical Centre, Loyola University Medical Centre, University of Medicine and Dentistry of new Jersy, USA
12:30-13:15
Lunch/Visit to Exhibition
13:15-15:15
Free paper session 4
13.15
4.1
The incidence of malignant disease among patients with deep vein thrombosis and deep vein thrombosis recurrences in these patients during and after anticoagulant treatment
Milic DJ, Zivic SS, Bogdanovic DC.
Clinic for Vascular Surgery, University Clinical Nis, Nis, Serbia
13.35
4.2
Evolving algorithm for the treatment of complex chronic venous disease
Neglen P, Darcey R, Raju S.
River Oaks Hospital, Flowood, MS, USA
13.55
4.2
Does it make sense to apply two light stockings over each other?
Partsch H, Partsch B, Wust M*.
Private Practice, Vienna, Austria.
* Salzmann Medico Laboratory, Wald, Switzerland
14.15
4.4
A validation study of a retrospective venous thromboembolism risk scoring method
Bahl V, Mei H, Henke P, Wakefield TW, Campbell DA, Caprini JA.
Northwestern Universtiy, Feinberg School of medicine, Chicago, Illinois, USA
14.35
4.5
Effect of the anticoagulant therapy in the thrombus regression: A prospective duplex ultrasound study
Romera-Villegas A, Cairols M, Vila-Coll R, Marti-Mestre X, Riera-Batalla S, Ballon-Carazas H.
Dept of Vascular Surgery, Hospital Universitari de Bellvitge, Barcelona, Spain
14.55
4.6
Chronic total occlusion of the iliocaval vein segment. Mid-term results of endovascular recanalization
Kolbel T, Lindh M, Akesson M, Ivancev K.
Vascular Centre, Malmo University Hospital, Malmo, Sweden. Submitted in consideration for the EVF Prize
15:15-15:45
Scientific merits of abstracts, presentations and papers Alun Davies, United Kingdom Chair: Joseph Caprini
15.45-16.00
Coffee break/Visit to Exhibition
16.00-16.30
EVF Invited Lecturer Newer approaches in treatment of DVT. Robert McLafferty Chair: Niels Bækgaard
16.30-18.30
Free Paper Session 5 Chair: Bo Eklöf, Michel Perrin
16.30
5.1
The effects of isolated phlebectomy on reflux and diameter of the great saphenous vein. A prospective study
Pittaluga P, Chastanet S, Locret T. Riviera Veine Institut, Nice, France Submitted in consideration for the EVF Prize
16.50
5.2
The risk of saphenofemoral recurrences without high ligation
Gianesini S, Menegatti E, Tacconi G, Palazzo A, Liboni A, Zamboni P.
Vascular Diseases Center, Department of Surgery, Ferrara University, Ferrara, Italy. Submitted in consideration for the EVF Prize
17.10
5.3
Popliteal vein reflux is frequent in hard-to-heal venous leg ulcers
Saarinen J*, Hjerppe A**, Venermo M*, Huhtala HS^, Vaalasti A**,
*Department of Vascular Surgery,
** Department of Dermatology,
^School of Public Health, University of Tampere, Tampere, Finland Submitted in consideration for the EVF Prize
17.30
5.4
Saphenectomy of the great saphenous vein without crossectomy: Six years follow up in a randomized study in 124 legs with terminal valve reflux
Casoni P.
Casi di Cura Citta di Parma, Sezione Chiirurgia Vascolare, Parma, Italy and Department of Phlebology, Molding Clinic, Marbella, Spain
17.50
5.5
Saphenous surgery is not a reliable cure for incompetent perforators in patients with venous ulcers
Nelzen O for the SWESEPS Study Group. Dept of Surgical Sciences, Uppsala University and Dept of Vascular Surgery, Skaraborg Hospital, Skovde, Sweden
18.10
5.6
Thigh compression with different compression devices after great sapenous vein surgery
Mosti G, Mattaliano V, Partsch H°
Clinica M.D. Barbantini, Angiology Department, Lucca, Italy,
°Private practice, Wien, Austria Submitted in consideration for the EVF Prize
19.30-20:15
Boat transfer to restaurant, including harbour view
20:15
Gala dinner: Langelinie Pavilionen, a restaurant furnished in classic Danish Design, with a beautiful harbour / seaside view and in walking distance of “The Little Mermaid”
Sunday 7. June
08.50-12.00
Free Paper Session 6 Chair: Morten Stahl Madsen, Marianne de Maeseneer
8.50
6.1
Follow-up of radiofrequency segmental thermal ablation (RTFA) of great sapehnous veins
Pichot O, Alm J*. CHU University Hospital, Grenoble, France,
*Department of Vascular Surgery, Dermatologikum Hamburg, Hamburg, Germany
9.10
6.2
Intraluminal fibre-tip centering can improve endovenous laser ablation: A histological study
Vuylsteke M, Van Dorpe J*, Roelens J**, De Bo Th, Mordon S^.
Department of Vascular Surgery, Surgery Sint-Andriesziekenhuis, Tielt, Belgium,
*Department of Pathology, Heilig-Hartziekenhuis, Roeselare, Belgium,
**Department of Pathology, Sint-Andriesziekenhuis, Tielt, Belgium, ^INSERM U 703, Lille University Hospital, Lille, France Submitted in consideration for the EVF Prize
9.30
6.3
Medium-term follow-up of a randomized trial comparing laser ablation with stripping of the GSV. Recurrence rate and pattern after 2 years
Rasmussen LH, Lawaetz M, Bjoern L, Lawaetz B, Blemings A, Eklof B. Areknudeklinikken,
The Danish Vein Centres and Surgical Clinic Roskilde, Denmark Submitted in consideration for the EVF Prize
9.50
6.4
A randomized trial of endovenous thermal ablation for superficial venous insufficiency of the great saphenous vein: Radiofrequency ablation versus endovenous laser therapy
Gale SS, Lee JN, Walsh ME, Wojnarowski DL, Comerota AJ. Jobst Vascular Centre, The Toledo Hospital, Toledo, Ohio, USA Submitted in consideration for the EVF Prize
10.10-10.40
Coffee break/Visit to Exhibition
10.40
6.5
Incidence of ultrasound visualisation of the sural nerve and echo-anatomical aspects
Ricci S, Moro L, Antonelli-Incalzi R.
Area di Geriatria, Centro per la Salute dell’Anziano, Universita Campus Bio-medico, Roma, Italy
11.00
6.6
Superficial venous reflux is a poor predictor of the impact of venous disease and subsequent treatment outcomes
Shepherd AC, Gohal MS, Lim CS, Hamish M, Davies AH. Imperial Vascular Unit, Imperial College, London, UK Submitted in consideration for the EVF Prize
11.20
6.7
Factors affecting postoperative pain following endovenous ablation of varicose veins
Gohel MS, Shepherd AC, Lim CS, Hamish M, Davies AH.
Imperial Vascular Unit, Imperial College, London, UK Submitted in consideration for the EVF Prize
11.40
6.8
Proteomic comparison of varicose veins in humans and in those that develop in a new porcine model of varicose veins
Van Rij AM, Philips LV, Bateman E, Madut D, Klefffman T*, Jones G.
Departments of Surgery and Biochemistry*,
University of Otago, Dunedin, New Zealand
12.00–12.40
Presentations from American Venous Forum (Servier Award Travelling Fellowship winners) Chair: Joe Caprini, Jawed Fareed
12.00
Pharmacomechanical thrombectomy for deep venous thrombois: An alternative for high risk patients
Rao S, Konig G, Leers SA, Cho JS, Marone LK, Rhee RY, Makaroun MS, Chaer RA.
University of Pittsburgh Medical Centre, Pittsburgh, PA, USA
12.20
Absorbable inferior vena cava filters (VCF): An in-vivo porcine model
A Thors, P MucK
Good Samaritan Hospital, Cincinnati, OH, USA
12.40–13.20
Presentations from winners of the EVF Pump Priming Grant Chair: Mehmet Kurtoglu, Marianne Vandendriessche
12.40
An economic study to evaluate and compare the costs of traditional and endovenous treatments.
Gohel M, Charing Cross Hospital, London, UK
13.00
The role of dysregulated apoptosis as a cellular response to hypoxia in the pathogenesis of varicose veins.
Lim CS, Charing Cross Hospital, London, UK
13:20 – 13.30
Presentation of prizes and closing remarks Niels Bækgaard and judges
